GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Mediclinic International PLC (OTCPK:ANHGY) » Definitions » 5-Year EBITDA Growth Rate

Mediclinic International (Mediclinic International) 5-Year EBITDA Growth Rate : 0.00% (As of Sep. 2022)


View and export this data going back to 2016. Start your Free Trial

What is Mediclinic International 5-Year EBITDA Growth Rate?

Mediclinic International's EBITDA per Share for the six months ended in Sep. 2022 was $0.40.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Competitive Comparison of Mediclinic International's 5-Year EBITDA Growth Rate

For the Medical Care Facilities subindustry, Mediclinic International's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mediclinic International's 5-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Mediclinic International's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Mediclinic International's 5-Year EBITDA Growth Rate falls into.



Mediclinic International 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Mediclinic International  (OTCPK:ANHGY) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Mediclinic International 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Mediclinic International's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Mediclinic International (Mediclinic International) Business Description

Traded in Other Exchanges
N/A
Address
65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ
Mediclinic International PLC is a UK based international private healthcare group. It is engaged in offering acute care, specialist-orientated and multi-disciplinary healthcare services, by operating many hospitals and clinics. The geographic operating segments of the company are Mediclinic Southern Africa, Mediclinic Switzerland, and Mediclinic Middle East. It derives the majority of the revenue from the Switzerland segment. The other non-operating segments of the company are the United Kingdom and Corporate. The group's operations are carried out under the Mediclinic and Hirslanden brand.

Mediclinic International (Mediclinic International) Headlines